494 related articles for article (PubMed ID: 33194697)
1. Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis.
Dumoulin DW; Gietema HA; Paats MS; Hendriks LEL; Cornelissen R
Front Oncol; 2020; 10():577696. PubMed ID: 33194697
[TBL] [Abstract][Full Text] [Related]
2. Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis.
Mallio CA; Napolitano A; Castiello G; Giordano FM; D'Alessio P; Iozzino M; Sun Y; Angeletti S; Russano M; Santini D; Tonini G; Zobel BB; Vincenzi B; Quattrocchi CC
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562011
[TBL] [Abstract][Full Text] [Related]
3. Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis.
Hindocha S; Hunter B; Linton-Reid K; George Charlton T; Chen M; Logan A; Ahmed M; Locke I; Sharma B; Doran S; Orton M; Bunce C; Power D; Ahmad S; Chan K; Ng P; Toshner R; Yasar B; Conibear J; Murphy R; Newsom-Davis T; Goodley P; Evison M; Yousaf N; Bitar G; McDonald F; Blackledge M; Aboagye E; Lee R
Radiother Oncol; 2024 Jun; 195():110266. PubMed ID: 38582181
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management.
Russano M; Citarella F; Napolitano A; Dell'Aquila E; Cortellini A; Pantano F; Vincenzi B; Tonini G; Santini D
Expert Opin Biol Ther; 2020 Sep; 20(9):959-964. PubMed ID: 32588674
[TBL] [Abstract][Full Text] [Related]
5. Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitors.
Isono T; Kagiyama N; Takano K; Hosoda C; Nishida T; Kawate E; Kobayashi Y; Ishiguro T; Takaku Y; Kurashima K; Yanagisawa T; Takayanagi N
Thorac Cancer; 2021 Jan; 12(2):153-164. PubMed ID: 33201587
[TBL] [Abstract][Full Text] [Related]
6. Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis.
Jung J; Kim HY; Kim DG; Park SY; Ko AR; Han JY; Kim HT; Lee JS; Lee Y
Cancer Res Treat; 2021 Jan; 53(1):77-86. PubMed ID: 32777877
[TBL] [Abstract][Full Text] [Related]
7. Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
Chen X; Sheikh K; Nakajima E; Lin CT; Lee J; Hu C; Hales RK; Forde PM; Naidoo J; Voong KR
Oncologist; 2021 Oct; 26(10):e1822-e1832. PubMed ID: 34251728
[TBL] [Abstract][Full Text] [Related]
8. Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Chu X; Zhao J; Zhou J; Zhou F; Jiang T; Jiang S; Sun X; You X; Wu F; Ren S; Zhou C; Su C
Lung Cancer; 2020 Dec; 150():76-82. PubMed ID: 33080551
[TBL] [Abstract][Full Text] [Related]
9. Radiological assessment of immunotherapy effects and immune checkpoint-related pneumonitis for lung cancer.
Hu Q; Wang S; Ma L; Sun Z; Liu Z; Deng S; Zhou J
J Cell Mol Med; 2023 Jul; 28(5):e17895. PubMed ID: 37525480
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.
Catania C; Stati V; Spitaleri G
Tumori; 2021 Jun; 107(3):267-269. PubMed ID: 32842909
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning.
Cheng J; Pan Y; Huang W; Huang K; Cui Y; Hong W; Wang L; Ni D; Tan P
Med Phys; 2022 Mar; 49(3):1547-1558. PubMed ID: 35026041
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis.
Osaki M; Arai T; Sumikawa H; Takimoto T; Takeuchi N; Tamiya A; Okishio K; Inoue Y
Oncology; 2023; 101(5):303-312. PubMed ID: 36689929
[TBL] [Abstract][Full Text] [Related]
13. Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.
Gambichler T; Reuther J; Scheel CH; Susok L; Kern P; Becker JC
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207589
[TBL] [Abstract][Full Text] [Related]
14. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
Serzan MT; Kumar PN; Atkins MB
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434789
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Ruiz JI; Lopez-Olivo MA; Geng Y; Suarez-Almazor ME
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36746512
[TBL] [Abstract][Full Text] [Related]
16. Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis.
Park C; Keam B; Yoon SH; Ock CY; Choi SM; Kim M; Park YS; Kim TM; Oh DY; Kim DW; Kim YW; Heo DS; Bang YJ
ESMO Open; 2019; 4(6):e000575. PubMed ID: 31803501
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.
Horiuchi K; Ikemura S; Sato T; Shimozaki K; Okamori S; Yamada Y; Yokoyama Y; Hashimoto M; Jinzaki M; Hirai I; Funakoshi T; Mizuno R; Oya M; Hirata K; Hamamoto Y; Terai H; Yasuda H; Kawada I; Soejima K; Fukunaga K
Oncologist; 2024 Jan; 29(1):e108-e117. PubMed ID: 37590388
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors in cancer patients with COVID-19.
Pan Y; Tan J; Li J; Li T; Li J; Cao Y; Yang L; Lin X; Li M; Liang X
Open Life Sci; 2023; 18(1):20220641. PubMed ID: 37426624
[TBL] [Abstract][Full Text] [Related]
19. Findings on Chest CT Performed in the Emergency Department in Patients Receiving Immune Checkpoint Inhibitor Therapy: Single-Institution 8-Year Experience in 136 Patients.
Smith DA; Radzinsky E; Tirumani SH; Guler E; Petraszko A; Kikano E; Hoimes CJ; Ramaiya NH
AJR Am J Roentgenol; 2021 Sep; 217(3):613-622. PubMed ID: 33295801
[No Abstract] [Full Text] [Related]
20. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.
Nobashi TW; Nishimoto Y; Kawata Y; Yutani H; Nakamura M; Tsuji Y; Yoshida A; Sugimoto A; Yamamoto T; Alam IS; Noma S
Br J Radiol; 2020 Nov; 93(1115):20200409. PubMed ID: 32783627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]